Intervillous macrophage migration inhibitory factor is associated with adverse birth outcomes in a study population in Central India.

Macrophage migration inhibitory factor (MIF) is a pluripotent factor produced by a variety of cells. It plays an important biological role in the regulation of pregnancy and has been shown to influence malaria pathogenesis. In this study, the levels of MIF in the peripheral, cord and placental inter...

Full description

Bibliographic Details
Main Authors: Puspendra P Singh, Naomi W Lucchi, Anna Blackstock, Venkatachalam Udhayakumar, Neeru Singh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3521649?pdf=render
_version_ 1823933234387353600
author Puspendra P Singh
Naomi W Lucchi
Anna Blackstock
Venkatachalam Udhayakumar
Neeru Singh
author_facet Puspendra P Singh
Naomi W Lucchi
Anna Blackstock
Venkatachalam Udhayakumar
Neeru Singh
author_sort Puspendra P Singh
collection DOAJ
description Macrophage migration inhibitory factor (MIF) is a pluripotent factor produced by a variety of cells. It plays an important biological role in the regulation of pregnancy and has been shown to influence malaria pathogenesis. In this study, the levels of MIF in the peripheral, cord and placental intervillous blood (IVB) plasma collected from women residing in a malaria endemic region of Central India was determined and its association with malaria in pregnancy and birth outcomes was investigated. MIF levels were significantly different in IVB, peripheral, and cord plasma, with IVB plasma having the highest MIF levels and peripheral plasma having the lowest. Placental malaria positive women had significantly higher IVB plasma MIF levels than placental malaria negative women, but this relationship was not seen in peripheral or cord plasma MIF levels. In addition, the odds of stillbirth and low birth weight deliveries for the uppermost placental MIF quartile (irrespective of placental malaria status) was significantly higher than that of the lowest placental MIF quartile, supporting the hypothesis that elevated concentrations of placental MIF may be associated with an increased risk of adverse birth outcome.
first_indexed 2024-12-16T22:03:25Z
format Article
id doaj.art-3c50869e21ae48e581dc504d10dba5eb
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-16T22:03:25Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-3c50869e21ae48e581dc504d10dba5eb2022-12-21T22:14:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01712e5167810.1371/journal.pone.0051678Intervillous macrophage migration inhibitory factor is associated with adverse birth outcomes in a study population in Central India.Puspendra P SinghNaomi W LucchiAnna BlackstockVenkatachalam UdhayakumarNeeru SinghMacrophage migration inhibitory factor (MIF) is a pluripotent factor produced by a variety of cells. It plays an important biological role in the regulation of pregnancy and has been shown to influence malaria pathogenesis. In this study, the levels of MIF in the peripheral, cord and placental intervillous blood (IVB) plasma collected from women residing in a malaria endemic region of Central India was determined and its association with malaria in pregnancy and birth outcomes was investigated. MIF levels were significantly different in IVB, peripheral, and cord plasma, with IVB plasma having the highest MIF levels and peripheral plasma having the lowest. Placental malaria positive women had significantly higher IVB plasma MIF levels than placental malaria negative women, but this relationship was not seen in peripheral or cord plasma MIF levels. In addition, the odds of stillbirth and low birth weight deliveries for the uppermost placental MIF quartile (irrespective of placental malaria status) was significantly higher than that of the lowest placental MIF quartile, supporting the hypothesis that elevated concentrations of placental MIF may be associated with an increased risk of adverse birth outcome.http://europepmc.org/articles/PMC3521649?pdf=render
spellingShingle Puspendra P Singh
Naomi W Lucchi
Anna Blackstock
Venkatachalam Udhayakumar
Neeru Singh
Intervillous macrophage migration inhibitory factor is associated with adverse birth outcomes in a study population in Central India.
PLoS ONE
title Intervillous macrophage migration inhibitory factor is associated with adverse birth outcomes in a study population in Central India.
title_full Intervillous macrophage migration inhibitory factor is associated with adverse birth outcomes in a study population in Central India.
title_fullStr Intervillous macrophage migration inhibitory factor is associated with adverse birth outcomes in a study population in Central India.
title_full_unstemmed Intervillous macrophage migration inhibitory factor is associated with adverse birth outcomes in a study population in Central India.
title_short Intervillous macrophage migration inhibitory factor is associated with adverse birth outcomes in a study population in Central India.
title_sort intervillous macrophage migration inhibitory factor is associated with adverse birth outcomes in a study population in central india
url http://europepmc.org/articles/PMC3521649?pdf=render
work_keys_str_mv AT puspendrapsingh intervillousmacrophagemigrationinhibitoryfactorisassociatedwithadversebirthoutcomesinastudypopulationincentralindia
AT naomiwlucchi intervillousmacrophagemigrationinhibitoryfactorisassociatedwithadversebirthoutcomesinastudypopulationincentralindia
AT annablackstock intervillousmacrophagemigrationinhibitoryfactorisassociatedwithadversebirthoutcomesinastudypopulationincentralindia
AT venkatachalamudhayakumar intervillousmacrophagemigrationinhibitoryfactorisassociatedwithadversebirthoutcomesinastudypopulationincentralindia
AT neerusingh intervillousmacrophagemigrationinhibitoryfactorisassociatedwithadversebirthoutcomesinastudypopulationincentralindia